bf/NASDAQ:KMDA_icon.jpeg

NASDAQ:KMDA

Kamada Ltd.

  • Stock

USD

Last Close

5.59

27/03 20:00

Market Cap

329.91M

Beta: 0.24

Volume Today

400

Avg: 21.91K

PE Ratio

42.09

PFCF: 184.28

  • industry

    Drug Manufacturers / Specialty & Generic
  • exchange

    NASDAQ Global Select
  • website

    www.kamada.com
  • ipo date

    Aug 01, 2005
  • full time employees

    380
  • currency

    USD

Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung...Show More

Earnings

Earnings per Share (Estimate*)

-0.10.10.20.30.42015-02-112017-02-062019-02-122021-02-102023-03-15

Revenue (Estimate*)

20M40M60M80M2015-02-112017-02-062019-02-122021-02-102023-03-15

*Estimate based on analyst consensus

Please Sign In To Use The Chat

The chat is only available for registered users, please sign in or create your free account.